Standard genetic testing for autism may be missing critical variants that could explain unsolved cases, potentially leaving families without answers about their child's condition. This limitation stems from short-read sequencing technologies that struggle to detect complex structural variants and DNA modifications across diverse genomic regions.
Researchers analyzed complete genome assemblies from 189 individuals across 51 families with unexplained autism cases using advanced long-read sequencing. They constructed near-complete genomes with exceptional quality scores and applied pangenome reference controls to filter out over 97% of common structural variants. The analysis identified three confirmed pathogenic variants in established autism genes TBL1XR1, MECP2, and SYNGAP1, plus nine additional candidate variants that conventional sequencing had missed entirely.
This pangenome approach represents a significant methodological advance for autism genetics. Unlike previous studies that relied on single reference genomes, this work captures genomic diversity across populations, revealing variants invisible to standard clinical testing. The findings suggest that structural variants on the X chromosome may contribute more significantly to autism risk in females than previously recognized, challenging current diagnostic assumptions. However, the study's relatively small sample size and focus on severe cases limits broader generalizability. The technology remains expensive and computationally intensive for routine clinical use, though costs are declining rapidly. For families with unexplained autism cases, this methodology offers new hope for identifying causative variants that could inform treatment strategies and genetic counseling, potentially solving cases that have remained mysterious for years.